LINDSAY JAMEEL: Open Payments
NPI 1629640107 · COVINGTON, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$395 in 5 payments from 4 companies in 2025. Trend: 2023 $297 · 2024 $439 · 2025 $395
Food & beverage: $395
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 2 | $229 |
| Neurocrine BioSciences, Inc. | 1 | $114 |
| Medline Industries LP | 1 | $37 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
Products named: AUSTEDO XR, REXULTI.
Industry payments across LA — which companies pay providers there.
